Manganese in gasoline. Council on Scientific Affairs, American Medical Association

Manganese exposure caused reproductive toxicity of male mice involving activation of GnRH secretion in the hypothalamus by prostaglandin E2 receptors EP1 and EP2

Exposure to manganese (Mn) can cause male reproductive damage and lead to abnormal secretion of sex hormones. Gonadotropin-releasing hormone (GnRH) plays an important role in the neuromodulation of vertebrate reproduction. Astrocytes can indirectly regulate the secretion of GnRH by binding paracrine prostaglandin E₂ (PGE₂) specifically to the EP1 and EP2 receptors on GnRH neurons. Prior studies assessed the abnormal secretion of GnRH caused by Mn exposure, but the specific mechanism has not been reported in detail. This study investigated the effects of Mn exposure on the reproductive system of male mice to clarify the role of PGE₂ in the abnormal secretion of GnRH in the hypothalamus caused by exposure to Mn. Our data demonstrate that antagonizing the EP1 and EP2 receptors of PGE₂ can restore abnormal levels of GnRH caused by Mn exposure. Mn exposure causes reduced sperm count and sperm shape deformities. These findings suggest that EP1 and EP2, the receptors of PGE₂, may be the key to abnormal GnRH secretion caused by Mn exposure. Antagonizing the PGE₂ receptors may reduce reproductive damage caused by Mn exposure.

Chronic exposure to manganese sulfate leads to adverse dose-dependent effects on the neurobehavioral ability of rats

Manganese sulfate is the main combustion product of methylcyclopentadienyl manganese tricarbonyl (MMT). Currently, little is known about the neurobehavioral consequences of chronic manganese sulfate exposure. In this study, rats were treated with 0, 5.0, 10.0, and 20.0 mg/kg MnSO₄ ·H₂ O for 24 consecutive weeks via intraperitoneal injection. During the treatment period, spatial learning-memory ability was measured using the Morris water maze (MWM). At the end of the exposure period, spontaneous motor behavior and emotional status, hippocampal histologic changes, and Hsp70 mRNA levels were measured using the open-field test (OFT), hematoxylin-eosin staining and real-time quantitative PCR (RT-PCR), respectively. A dose-dependent decrease was noted in the spatial learning-memory ability and the spontaneous activities of rats (P < 0.05), and negative emotions differed significantly between the exposed groups and the control group (P < 0.05). Moreover, overt morphological changes in the hippocampuses of the exposed rats were detected. Cellular degeneration and death were also found. The Hsp70 mRNA levels of the hippocampal areas in the 20.0 mg/kg group (1.567 ± 0.236) were significantly increased compared with the control group (P < 0.05). These results suggest that chronic exposure to manganese sulfate can have adverse dose-dependent effects on rats' neurobehavioral ability, and the mechanism of abnormal hippocampal Hsp70 expression needs to be further explored. © 2015 Wiley Periodicals, Inc. Environ Toxicol 31: 1571-1579, 2016.

A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities

There is concern that industrial emissions of manganese (Mn) and the use of Mn-containing compounds as fuel additives might increase the population risk of Parkinson's disease (PD)-like disorders. We investigated associations between the diagnosis and treatment of PD and markers of exposure to vehicle exhaust and industrial emissions of Mn within a cohort of 110,000 subjects in the cities of Toronto and Hamilton, Canada. Methylcyclopentadienyl manganese tricarbonyl (MMT) has been added to Canadian gasoline since 1976 and steelmaking in Hamilton emits Mn to the air. Using residential postal codes, subjects were mapped to: (1) residence locations close to traffic and to neighbourhood levels of NO2, as markers of traffic-generated air pollution (TGAP); and, (2) neighbourhood levels of ambient Mn in Hamilton, as measured by the Mn fraction of total suspended particulate. Subjects were linked to Ministry of Health administrative databases, 1992-1999, to identify physicians' diagnoses of PD and prescriptions for l-Dopa containing medications. In Toronto, we found no association between PD and the markers of TGAP. In Hamilton, the odds ratio for a physician's diagnosis of PD was 1.034 (1.00-1.07) per 10 ng/m3 increase in Mn in TSP. The estimate of the "doubling exposure" for physician-diagnosed PD was about 150 ng/m3 Mn in TSP. Examination of prevalence curves suggested that exposure to ambient Mn advances the age of diagnosis of PD, consistent with the theory that exposure to Mn adds to the natural loss of neurons attributable to the aging process.

Adequacy and consistency of animal studies to evaluate the neurotoxicity of chronic low-level manganese exposure in humans

The adequacy of existing animal studies to understand the effects of chronic low-level manganese exposures in humans is unclear. Here, a collection of subchronic to chronic rodent and nonhuman primate studies was evaluated to determine whether there is a consistent dose-response relationship among studies, whether there is a progression of effects with increasing dose, and whether these studies are adequate for evaluating the neurotoxicity of chronic low-level manganese exposures in humans. Neurochemical and behavioral effects were compared along the axis of estimated internal cumulative manganese dose, independent of the route of exposure. In rodents, motor effects emerged at cumulative doses below those where occupationally exposed humans start to show motor deficits. The main neurochemical effects in rodents were an increase in striatal gamma-aminobutyric acid (GABA) concentration throughout the internal cumulative dose range of 18 to 5300 mg Mn/kg but a variable effect on striatal dopamine concentration emerging at internal cumulative doses above approximately 200 mg Mn/kg. Monkey studies showed motor deficits and effects on the globus pallidus at relatively low doses and consistent harmful effects on both the globus pallidus and the caudate and putamen at higher doses (> 260 mg Mn/kg). Internal cumulative manganese doses of animal studies extend more than two orders of magnitude (< 1 to 5300 mg Mn/kg) above the doses at which occupationally exposed humans show neurological dysfunction (10-15 mg Mn/kg). Since the animal data indicate that manganese neurotoxicity may be different at low compared to elevated exposures, most existing animal model studies might be of limited relevance for the risk assessment of chronic low-level manganese exposure to humans.

Manganese concentrations in the soil and air in the vicinity of a closed manganese alloy production plant

In Montreal (Canada), the mean annual atmospheric Mn concentrations between 1981 and 1990 were stable, followed by a decrease of almost 50% from 1990 to 1992. The reason for such a decrease in Mn is probably the shutdown of a large manganese alloy production plant in Beauharnois, approximately 25 km from Montreal. The objective of this study is to assess the level of air and soil contamination by Mn in the vicinity of this ferroalloy plant more than 10 years after its closure. Air and soil were sampled over 5 days at two and three sites, respectively. Site 1 was located 10 m NE of the closed plant, in the direction of the prevailing SW-NE winds. Sites 2 and 3 were at 50 and 800 m SE from the plant. Air samples were collected in order to determine total (MnT) and respirable (MnR). Soil samples were taken in the surface and subsurface strata. The results show that site 1 is extremely polluted with a mean Mn concentration in surface strata of 2,66,000+/-45,000 ppm and 2,83,000+/-23,000 ppm in the subsurface strata, while the average MnT and MnR are 21.9+/-13.7 and 3.5+/-3.9 microg/m(3), respectively. The explanation for this contamination is direct deposition on the soil of solid Mn-rich residue and atmospheric erosion of Mn particles. The situation should be remediated by the public authority with high priority.

Blood manganese concentrations among first-grade schoolchildren in two South African cities

Little information exists on the environmental exposures to low levels of organometallic manganese (a principal combustion product from manganese-containing fuel additives) and public health. This study was undertaken to establish biological and environmental levels of manganese among first-grade schoolchildren in the South African cities of Johannesburg and Cape Town. The study was undertaken subsequent to partial introduction of the manganese-containing fuel additive methylcyclopentadienyl manganese tricarbonyl (MMT) to South African petrol in the Johannesburg region only, about 24 months prior to the commencement of the study, and in anticipation of possible future increases in MMT use in the rest of the country. This study involved the measurement of manganese concentrations in the blood of the total number of 814 of grade one schoolchildren (430 and 384 in Cape Town and Johannesburg, respectively), and in water supplies, soil, and classroom dust at a total number of 21 participating schools. The results indicated higher concentrations of manganese in school soil (P=0.0007) and dust (P=0.0071) samples from Johannesburg relative to Cape Town. Similarly, the mean blood manganese concentration in Johannesburg study subjects (9.80 microg/L, SD 3.59) was significantly higher than that in Cape Town study subjects (6.74 microg/L, SD 3.47), after allowing for the clustering effect within schools and adjusting for the confounding effect of population group (P<0.0001). The blood manganese levels of 4.2% and 12.5% of children in Cape Town and Johannesburg, respectively, equaled or exceeded 14 microg/L, the upper normal reference value specified by the Agency for Toxic Substances Disease Registry (ATSDR, 2000). Importantly, levels of manganese in blood were found to be significantly associated with concentrations of manganese in classroom dust at schools.

Total suspended particulate manganese in ambient air in Montreal 1981-2000

Our research group previously established the time variation of atmospheric Mn in Montreal for the period 1981-1992. The results indicated stable Mn concentrations between 1981 and 1990 followed by a decrease of almost 50% attributed to the closing of a ferromanganese plant located approximately 25 km from Montreal. The aim of this study is to assess the atmospheric concentrations of Mn in Montreal between 1993 and 2000, to compare these data to those for the period 1981-1992, and to evaluate the presence of any trend. Three sampling stations belonging to the Montreal Urban Community (MUC) air quality surveillance network were selected. Filters from 1993 to 2000 were obtained from the MUC archives. The first sample of each month was selected and chemical analysis was performed by neutron activation analysis. The mean annual atmospheric Mn concentrations in Montreal from 1993 to 2000 were found to be very stable. The mean Mn concentration calculated for this time period was 0.01 microg/m(3) for station 99 (characterized by a low traffic density), which was significantly different (P<0.05) from the mean of 0.03 microg/m(3) for stations 13 and 68 which had higher traffic densities. Even though Mn represented a small percentage of the TSP (varying between 0.02% and 0.14%), the comparison between Mn and TSP is interesting since the stable temporal profile of Mn since 1993 contrasts with the continuously decreasing atmospheric TSP concentrations. This observation suggests that the combustion of MMT used in gasoline could be contributing to maintaining stable atmospheric Mn levels.

Neurologic effects of manganese in humans: a review

Manganese, which enters the body primarily via inhalation, can damage the nervous system and respiratory tract, as well as have other adverse effects. Occupational exposures occur mainly in mining, alloy production, processing, ferro-manganese operations, welding, and work with agrochemicals. Among the neurologic effects is an irreversible parkinsonian-like syndrome. An estimated 500,000 to 1.5 million people in the United States have Parkinson's disease, and physicians need to consider manganese exposure in its differential diagnosis. Since 1837, there have been many reports of cases and case series describing manganese toxicity. More recently, there have been epidemiologic studies of its adverse effects on health. Occupational medicine physicians can play critical roles in preventing the adverse health effects of manganese.

Manganese neurotoxicity: behavioral, pathological, and biochemical effects following various routes of exposure

The human central nervous system is an important target for manganese intoxication, which causes neurological symptoms similar to those of Parkinson's disease. With the increasing use of methylcyclopentadienyl manganese tricarbonyl (MMT) as an octane-improving additive to unleaded gasoline, the prospect of worldwide manganese exposure is once again attracting attention as increases in environmental manganese concentrations have been recorded relative to traffic density. One crucial question is whether a small increase of manganese contamination resulting from the widespread use of MMT could have neurotoxic effects. In this review we concentrate on central nervous system abnormalities and neurobehavioral disturbances. Most experimental animal studies on manganese neurotoxicity have been conducted in nonhuman primates and rodents. Most studies performed in rodents used oral manganese administration and did not assess bioaccumulation or central nervous system changes. The major effect found was transient modification of spontaneous motor activity. Very few inhalation toxicological studies were carried out. As manganese intoxication in humans usually occurs via inhalation, more studies are required using the respiratory route of administration. Given the proven neurotoxic effects of manganese and the prospect of worldwide MMT usage, this metal should be considered a new environmental pollutant having potentially widespread public health consequences.

Use of MMT in Canadian gasoline: health and environment issues

BACKGROUND

Methylcyclopentadienyl manganese tricarbonyl (MMT) is an organic derivative of manganese (Mn) used in Canadian gasoline since 1976 as an antiknock agent and to improve octane rating. Combustion products of MMT are mainly a mixture of Mn phosphate and Mn sulfate. In 1997, the Canadian federal government adopted a law (C-29) which banned both the interprovincial trade and the importation for commercial purposes of manganese-based substances, including MMT. However, the government reworded this law in July 1998 so that manganese-based fuel additives were not included in the restrictions. MMT is now approved for use in Argentina, Australia, Bulgaria, the United States, France, Russia, and conditionally in New Zealand. Nevertheless, these countries are not using MMT intensively and they are waiting for strong evidence of the absence of effects on human health. Even after several years of use of MMT in Canada, many uncertainties remain.

METHODS

Different methods were used in order to assess (1) environmental contamination and human exposure to the parental form of MMT, (2) nitrogen oxides (NO(x)) and carbon monoxide (CO) emissions associated with the use of MMT, and (3) qualitative and quantitative assessments of Mn emissions to the environment.

RESULTS

The results provide timely information with regard to the impact of MMT on environmental/ecosystem Mn contamination in abiotic and biotic systems as well as on human exposure. Moreover, results raise major concerns with regard to public health effects related to exposure to Mn.

CONCLUSIONS

Obviously, there is still an important lack of adequate toxicological information and further studies are needed to provide successful implementation of evidence-based risk assessment approaches.